Evidence map›Paper›PMID 39708122›Full record

ArticleHuman genetics2025

Further evidence of biallelic NAV3 variants associated with recessive neurodevelopmental disorder with dysmorphism, developmental delay, intellectual disability, and behavioral abnormalities.

Naseebullah Kakar, Selinda Mascarenhas, Asmat Ali, Azmatullah, Syed M Ijlal Haider, Vaishnavi Ashok Badiger, Mobina Shadman Ghofrani, Nathalie Kruse, Sohana Nadeem Hashmi, Jelena Pozojevic and 9 more

Abstract read
In one paragraph

Article in Human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Naseebullah KakarInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Selinda Mascarenhas *Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Asmat Ali *Department of Biological and Biomedical Science, The Aga Khan University, Stadium Road, Karachi, 78400, Pakistan.
Azmatullah *Department of Zoology, Human Genetics Program, Quaid-i-Azam University, Islamabad, Pakistan.
Syed M Ijlal HaiderInstitute for Cardiogenetics, University of Lübeck, Lübeck, Germany.
Vaishnavi Ashok BadigerDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Mobina Shadman GhofraniInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Nathalie KruseInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Sohana Nadeem HashmiDepartment of Biological and Biomedical Science, The Aga Khan University, Stadium Road, Karachi, 78400, Pakistan.
Jelena PozojevicInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Saranya BalachandranInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Mathias ToftInstitute of Clinical Medicine, University of Oslo, P.O Box 1171, 0318, Oslo, Norway.
Sajid MalikDepartment of Zoology, Human Genetics Program, Quaid-i-Azam University, Islamabad, Pakistan.
Kristian HändlerInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany.
Ambrin FatimaDepartment of Biological and Biomedical Science, The Aga Khan University, Stadium Road, Karachi, 78400, Pakistan.
Zafar IqbalDepartment of Neurology, Oslo University Hospital, Nydalen, P.O. Box 4950, 0424, Oslo, Norway.
Anju ShuklaDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Malte SpielmannInstitut für Humangenetik, Universitätsklinikum Schleswig-Holstein, University of Lübeck and University of Kiel, 23562, Lübeck, Germany. malte.spielmann@uksh.de.
Periyasamy RadhakrishnanDepartment of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India. p.radhakrishnan@manipal.edu.

Funding

Alexander von Humboldt Foundation, Germany FellowshipDBT-Wellcome Trust India Alliance IA/CRC/20/1/600002DBT/Wellcome Trust India Alliance for the study, "Centre for Rare Disease Diagnosis, Research and Training IA/CRC/20/1/600002ICGEB grant CRP/PAK21-05_ECORIC, BUITEMS Startup grantsWellcome Trust
6 · The paper itself

Abstract

Neuron navigators (NAVs) are cytoskeleton-associated proteins well known for their role in axonal guidance, neuronal migration, and neurite growth necessary for neurodevelopment. Neuron navigator 3 (NAV3) is one of the three NAV proteins highly expressed in the embryonic and adult brain. However, the role of the NAV3 gene in human disease is not well-studied. Recently, five bi-allelic and three mono-allelic variants in NAV3 were reported in 12 individuals from eight unrelated families with neurodevelopmental disorder (NDD). Here, we report five patients from three unrelated consanguineous families segregating autosomal recessive NDD. Patients have symptoms of dysmorphism, intellectual disability, developmental delay, and behavioral abnormalities. Exome sequencing (ES) was performed on two affected individuals from one large family, and one affected individual from each of the other two families. ES revealed two homozygous nonsense c.6325C > T; p.(Gln2109Ter) and c.6577C > T; p.(Arg2193Ter) and a homozygous splice site (c.243 + 1G > T) variants in the NAV3 (NM_001024383.2). Analysis of single-cell sequencing datasets from embryonic and young adult human brains revealed that NAV3 is highly expressed in the excitatory neurons, inhibitory neurons, and microglia, consistent with its role in neurodevelopment. In conclusion, in this study, we further validate biallelic protein truncating variants in NAV3 as a cause of NDD, expanding the spectrum of pathogenic variants in this newly discovered NDD gene.

Indexed as

Developmental DisabilitiesIntellectual DisabilityNerve Tissue ProteinsNeurodevelopmental DisordersAdolescentAdultAllelesChildChild, PreschoolConsanguinityExome SequencingFemaleGenes, RecessiveHumansMalePedigreeNerve Tissue Proteins

Identifiers

PMID39708122
PMCPMC11754320

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.